However, CDK12-inactivated ovarian and prostate tumours present a unique genome instability phenotype, pointing to a unique deregulation of genome stability (likely by aberrant DNA replication-associated HR-dependent repair) leading to tumorigenesis. The gene discussed is CDK12; the disease is prostate neoplasm.